DK2326645T3 - Forbindelse med serotoninergisk aktivitet, proces til fremstilling deraf samt farmaceutisk sammensætning omfattende forbindelsen - Google Patents

Forbindelse med serotoninergisk aktivitet, proces til fremstilling deraf samt farmaceutisk sammensætning omfattende forbindelsen

Info

Publication number
DK2326645T3
DK2326645T3 DK09802482.1T DK09802482T DK2326645T3 DK 2326645 T3 DK2326645 T3 DK 2326645T3 DK 09802482 T DK09802482 T DK 09802482T DK 2326645 T3 DK2326645 T3 DK 2326645T3
Authority
DK
Denmark
Prior art keywords
compound
preparation
pharmaceutical composition
serotoninergic activity
serotoninergic
Prior art date
Application number
DK09802482.1T
Other languages
English (en)
Inventor
Lorenzo Polenzani
Maria Alessandra Alisi
Nicola Cazzolla
Roberta Costi
Santo Roberto Di
Guido Furlotti
Angelo Guglielmotti
Original Assignee
Acraf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Acraf filed Critical Acraf
Application granted granted Critical
Publication of DK2326645T3 publication Critical patent/DK2326645T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Neurology (AREA)
  • Endocrinology (AREA)
  • Pain & Pain Management (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DK09802482.1T 2008-07-29 2009-07-17 Forbindelse med serotoninergisk aktivitet, proces til fremstilling deraf samt farmaceutisk sammensætning omfattende forbindelsen DK2326645T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP08425516 2008-07-29
PCT/EP2009/059216 WO2010012611A1 (en) 2008-07-29 2009-07-17 Compound with serotoninergic activity, process for preparing it and pharmaceutical composition comprising it

Publications (1)

Publication Number Publication Date
DK2326645T3 true DK2326645T3 (da) 2013-02-18

Family

ID=40229874

Family Applications (1)

Application Number Title Priority Date Filing Date
DK09802482.1T DK2326645T3 (da) 2008-07-29 2009-07-17 Forbindelse med serotoninergisk aktivitet, proces til fremstilling deraf samt farmaceutisk sammensætning omfattende forbindelsen

Country Status (21)

Country Link
US (1) US8686147B2 (da)
EP (1) EP2326645B9 (da)
JP (1) JP5536771B2 (da)
KR (1) KR101646093B1 (da)
CN (1) CN102099358B (da)
AR (1) AR072604A1 (da)
AU (1) AU2009276082B2 (da)
BR (1) BRPI0916401A2 (da)
CA (1) CA2728096C (da)
DK (1) DK2326645T3 (da)
EA (1) EA019300B1 (da)
ES (1) ES2399066T3 (da)
GE (1) GEP20135858B (da)
HK (1) HK1153195A1 (da)
IL (1) IL210049A (da)
MX (1) MX2011001088A (da)
PL (1) PL2326645T3 (da)
PT (1) PT2326645E (da)
SI (1) SI2326645T1 (da)
UA (1) UA103026C2 (da)
WO (1) WO2010012611A1 (da)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11807639B1 (en) 2023-03-23 2023-11-07 King Faisal University Pyrrolo[3,4-b]quinoline compounds as antibacterial agents

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4350814A (en) * 1979-10-22 1982-09-21 Ici Americas Inc. Pyrrolo [3,4-c]quinoline compounds
US4268513A (en) 1979-10-22 1981-05-19 Ici Americas Inc. Pyrrolo [3,4-c]quinoline compounds and pharmaceutical compositions, methods for their use and preparation
US4440768A (en) 1981-01-08 1984-04-03 Ici Americas Inc. Hexahydropyrrolo[3,4-c]quinoline compounds and pharmaceutical compositions, and methods for their use
US5243049A (en) 1992-01-22 1993-09-07 Neurogen Corporation Certain pyrroloquinolinones: a new class of GABA brain receptor ligands
GB2316072B (en) * 1996-08-05 2000-05-10 Pharmacia Spa Pyrrolo[3,2-c]quinoline derivatives
KR100251522B1 (ko) 1997-08-13 2000-08-01 김충섭 할로알콕시기를 함유하는 피롤[3,2-c]퀴놀린 유도체 및 약학적으로 허용되는 그의 염
IT1303123B1 (it) 1998-10-13 2000-10-30 Rotta Research Lab Derivati basici di benz(e)isoindol-1-oni e pirrolo(3,4-c)chinolin-1-oni ad attivita' 5ht3 antagonista, loro preparazione ed
FR2792937B1 (fr) 1999-04-27 2001-08-10 Cemaf NOUVEAUX DERIVES DE PYRROLO-(3,4-b) QUINOLEINE, LEUR PROCEDE DE PREPARATION ET LEUR UTILISATION A TITRE DE MEDICAMENT
ITMI20030972A1 (it) 2003-05-15 2004-11-16 Acraf Indazolo dotato di attivita' analgesica, metodo per prepararlo e composizione farmaceutica che lo comprende.
ITMI20031468A1 (it) 2003-07-18 2005-01-19 Acraf Farmaco ativo nel dolore neuropatico
JP4613029B2 (ja) 2004-04-21 2011-01-12 阿蘇製薬株式会社 ２Ｈ−ピロロ［３，４−ｂ］キノリン誘導体

Also Published As

Publication number Publication date
ES2399066T3 (es) 2013-03-25
GEP20135858B (en) 2013-06-25
AR072604A1 (es) 2010-09-08
IL210049A0 (en) 2011-02-28
US8686147B2 (en) 2014-04-01
SI2326645T1 (sl) 2013-02-28
CN102099358B (zh) 2014-01-22
AU2009276082B2 (en) 2014-01-23
MX2011001088A (es) 2011-07-29
JP2011529462A (ja) 2011-12-08
EA019300B1 (ru) 2014-02-28
EP2326645B1 (en) 2012-11-07
EP2326645A1 (en) 2011-06-01
HK1153195A1 (en) 2012-03-23
KR101646093B1 (ko) 2016-08-05
UA103026C2 (ru) 2013-09-10
AU2009276082A1 (en) 2010-02-04
CA2728096A1 (en) 2010-02-04
CA2728096C (en) 2017-01-03
CN102099358A (zh) 2011-06-15
PT2326645E (pt) 2012-12-27
JP5536771B2 (ja) 2014-07-02
BRPI0916401A2 (pt) 2016-02-16
EP2326645B9 (en) 2013-04-17
PL2326645T3 (pl) 2013-04-30
KR20110033999A (ko) 2011-04-04
WO2010012611A1 (en) 2010-02-04
US20110160201A1 (en) 2011-06-30
EA201170268A1 (ru) 2011-06-30
IL210049A (en) 2015-03-31

Similar Documents

Publication Publication Date Title
IL269858A (en) Pyridone and aza-pyridone compounds, pharmaceutical composition and kits comprising the same and uses thereof
DK2282994T3 (da) 3-aminocarbazolforbindelse, farmaceutisk sammensætning indeholdende forbindelsen samt fremstillingsmetode derfor
AP3346A (en) Novel compounds effective as xanthine oxidase inhibitors, method for preparing the same, and pharmaceutical composition containing the same
BRPI0906962A2 (pt) Composto, e, composição farmacêutica
BRPI0906556A2 (pt) Composto, e, composição farmacêutica
DK2108260T3 (da) Sammensætning med biocid aktivitet til vandige præparater
IL225198A (en) Aminotetrahydropyrenic Compounds, Pharmaceutical Preparations Containing Them and Their Use in the Treatment of Diabetes
DK3309139T3 (da) Process for the preparation of 2,3,3,3-trifluoropropene
BR112012022879A2 (pt) composto, composição farmacêutica, uso do composto e método de tratamento
IL211400A0 (en) Substituted aminoindanes and analogs thereof, and the pharmaceutical use thereof
BR112012004335A2 (pt) composto, composição farmacêutica, e, uso do composto.
BRPI0809661A2 (pt) Composição farmacêutica estabilizada contendo pregabalina
CL2007002377A1 (es) Compuestos derivados de quinazolina; procedimiento de preparacion; composicion farmaceutica; y su uso como anticancerigeno.
BRPI0922233A2 (pt) compostos, composições farmacêiticas e métodos para uso no tratamento de síndromes metabólicas.
BRPI0917681A2 (pt) Composto, e, composição farmacêutica
HK1200446A1 (zh) 哌啶化合物、含有該化合物的藥物組合物及其用途
EP2366691A4 (en) NITROPYRIDINYL ETHYLENE HYIN, PHARMACEUTICAL COMPOSITION INCLUDING THE SAME, SYNTHESIS METHOD AND APPLICATIONS THEREOF
FI20070395A0 (fi) Fotokatalyyttisesti aktiivinen koostumus ja menetelmä sen valmistamiseksi
BRPI0720323A2 (pt) composto, método de tratamento, composição farmacêutica e uso do composto
BRPI0911772A2 (pt) composto, composição farmacêutica, e, uso do composto.
BRPI0914182A2 (pt) composto, e, composição farmacêutica
SI2320739T1 (sl) Farmacevtski sestavki in postopki za njihovo stabiliziranje
BR112013023575A2 (pt) “derivado de octaidrotienoquinolina, composição farmacêutica compreendendo o derivado, e uso destes”
BR112012002311A2 (pt) composto, composição farmacêutica, e, uso do composto.
DK2326645T3 (da) Forbindelse med serotoninergisk aktivitet, proces til fremstilling deraf samt farmaceutisk sammensætning omfattende forbindelsen